Bausch + Lomb (NYSE:BLCO – Get Free Report) is expected to be issuing its Q2 2026 results before the market opens on Wednesday, July 29th. Analysts expect the company to announce earnings of $0.16 per share and revenue of $1.3694 billion for the quarter. Investors can find conference call details on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 8:00 AM ET.
Bausch + Lomb (NYSE:BLCO – Get Free Report) last issued its earnings results on Wednesday, April 29th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.02. Bausch + Lomb had a negative net margin of 4.21% and a positive return on equity of 3.60%. The business had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.07) EPS. On average, analysts expect Bausch + Lomb to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Bausch + Lomb Trading Up 0.0%
NYSE BLCO opened at $15.99 on Wednesday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.53 and a quick ratio of 0.99. The firm’s fifty day moving average price is $15.89 and its 200 day moving average price is $16.46. The company has a market capitalization of $5.71 billion, a price-to-earnings ratio of -25.78, a price-to-earnings-growth ratio of 0.49 and a beta of 0.56. Bausch + Lomb has a 12 month low of $13.09 and a 12 month high of $18.92.
Analyst Upgrades and Downgrades
Read Our Latest Report on Bausch + Lomb
Institutional Trading of Bausch + Lomb
A number of large investors have recently bought and sold shares of the business. Cetera Investment Advisers grew its holdings in shares of Bausch + Lomb by 3.9% during the fourth quarter. Cetera Investment Advisers now owns 18,713 shares of the company’s stock worth $320,000 after buying an additional 711 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in Bausch + Lomb by 38.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,757 shares of the company’s stock valued at $64,000 after acquiring an additional 1,039 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its position in Bausch + Lomb by 104.1% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,227 shares of the company’s stock worth $38,000 after acquiring an additional 1,136 shares during the period. Wells Fargo & Company MN lifted its position in Bausch + Lomb by 31.2% during the 4th quarter. Wells Fargo & Company MN now owns 5,903 shares of the company’s stock worth $101,000 after acquiring an additional 1,403 shares during the period. Finally, Woodline Partners LP lifted its position in Bausch + Lomb by 0.5% during the 1st quarter. Woodline Partners LP now owns 312,823 shares of the company’s stock worth $4,536,000 after acquiring an additional 1,436 shares during the period. Institutional investors and hedge funds own 11.07% of the company’s stock.
Bausch + Lomb Company Profile
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.
Featured Stories
- Five stocks we like better than Bausch + Lomb
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for Bausch + Lomb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch + Lomb and related companies with MarketBeat.com's FREE daily email newsletter.
